INSIGHTS ON UPSTREAM MANUFACTURING
-
![GettyImages-2161101968 lymphocytes]( "The Importance Of Starting Material In Breakthrough Cancer Treatments")
The Importance Of Starting Material In Breakthrough Cancer TreatmentsAutologous TIL therapy starts with patient biology no developer can standardize. Discover which parts of the process can be controlled, and how far that goes toward reproducible products.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Breaking The DoE Bottleneck In Biologics Development")
Breaking The DoE Bottleneck In Biologics DevelopmentAdvanced screening designs reduce experimental burden while identifying critical process parameters, accelerating biomanufacturing optimization and process development.
-
![Targeted Gene Therapies, AI-Powered Genomic Analysis-GettyImages-2196602729]( "Biologics Characterization Through Machine Learning")
Biologics Characterization Through Machine LearningSpace-filling designs and ensemble machine learning can characterize a six-factor gene therapy process in just 24 runs, reducing time and materials.
-
![Collaborating For Supply Chain Resilience Bucket]( "Collaborating For Supply Chain Resilience")
Collaborating For Supply Chain ResilienceCell culture media supply resilience shapes continuity. A global CDMO's approach to tariff exposure spans both proprietary formulations and standard media, showing how supply strategy holds up.
-
Enabling Commercial-Scale Biologics Manufacturing With Media Services10/28/2026
Consistent cell culture media across development underpins reliability at scale. Integrated manufacturing addresses supply, quality, and shelf-life uncertainty that can ripple into commitments.
-
Rethinking Starting Material: Whole Blood For Autologous T-Cell Manufacture10/28/2026
Matching starting material to process requirements in autologous T-cell manufacturing, and where whole blood may stand in for leukapheresis without compromising what the process needs.
-
3-In-1 Protocol For Rapid CAR-T Cell Manufacturing10/28/2026
Closing the process and merging three steps into one perfusion run brings CAR-T manufacturing down to roughly a week, with fewer open events and lower batch failure risk.
-
A Robust System For High-Titer, Platform-Agnostic AAV Production In HEK293 Cells10/23/2026
AAV titer and full capsid enrichment depend on tuning every process component, starting with the medium. Results across serotypes, reagents, and enhancers show how far a media-led approach can go.
UPSTREAM MANUFACTURING SOLUTIONS
-
![CAR T Cells-GettyImages-2196144750]( "TheraPEAK® ActiCell® T Cell Activation Reagent")
Bead-free activation of human T cells through biodegradable nanoparticles aims to protect cell health during expansion, with the reagent cleared by simple washing or centrifugation.
-
![GettyImages-2160387631 cells]( "Quantum Flex Cell Expansion System: Inspired By Human Biology, Designed To Scale")
Cell expansion built around low seeding requirements and high yields in 1 L or less. A bioreactor design drawn from human biology aims to simplify scale-up.
-
![Team collaboration, planning for property development-GettyImages-1796900872]( "Guaranteed Tech Transfer And Process Development – Or Your Money Back")
De-risk biotech development with guaranteed tech transfer and process support. Safeguard your investment from cell line development through protein optimization.
-
![Nunc Cell Factory Systems]( "Nunc Cell Factory Systems: For Consistent Cell Culture Performance")
Scaling adherent cell culture from flasks to multilayer systems depends on surface consistency, aseptic connections, and more. See how ultrasonic welding and retention hardware shape that path.
-
![cell-and-gene-therapy-GettyImages-2272229186]( "Viral Vector CDMO Services From Design To GMP Delivery")
Integrated viral vector development, testing, and GMP supply, paired with engineered plasmids and cell lines to reduce scale-up risk and improve yield.
